Press Releases from Dr. Wolz Zell GmbH, Germany (3 total)
The EHEC disaster – opportunities for the early treatment of acutely ill patie …
Reports on the therapeutic options for the treatment of hemorrhagic diarrhoea and the prophylaxis of life-threatening complications like HUS as a result of the infection with „Killer Coli“, as enterohaemorrhagic Escherichia coli (EHEC) is termed sometimes, are often evidence of a degree of uncertainty and above all a lack of knowledge with regards to proven and tested therapeutic treatments.
In the context of the epidemic of severe EHEC cases which…
The EHEC disaster – opportunities for the early treatment of acutely ill patie …
Reports on the therapeutic options for the treatment of hemorrhagic diarrhoea and the prophylaxis of life-threatening complications like HUS as a result of the infection with „Killer Coli“, as enterohaemorrhagic Escherichia coli (EHEC) is termed sometimes, are often evidence of a degree of uncertainty and above all a lack of knowledge with regards to proven and tested therapeutic treatments.
In the context of the epidemic of severe EHEC cases…
Fibromyalgia – The possibilities of treating chronic and chronic-recurrent pai …
Germany, Geisenheim, February 2009 – A group of renowned pain therapists and immunologists have established that a treatment with LACTOBIN® N leads to a significant pain abatement in up to 40% of patients with Fibromyalgia or chronic-recurrent pain syndromes. In some the effect was a complete pain relief.
This was the result of the clinical testing of LACTOBIN® N or bioequivalent preparations with several hundred fibromyalgia patients. Several years of research…
Go To Page: 1
